Matches in Nanopublications for { ?s ?p "[Prevalence of cagA and cagE genes in the patients with NUD, DU, GU and GC were 22 (64.7%), 28 (100%), 18 (90%), 10 (100%) and 25 (73.5%), 27 (96.4%), 19 (95%), 7 (70%), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP723768.RAePpPoeDIpdrDzsXrkHidb0tLMIxT2R1gCP-qyCCoUHE130_assertion description "[Prevalence of cagA and cagE genes in the patients with NUD, DU, GU and GC were 22 (64.7%), 28 (100%), 18 (90%), 10 (100%) and 25 (73.5%), 27 (96.4%), 19 (95%), 7 (70%), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP723768.RAePpPoeDIpdrDzsXrkHidb0tLMIxT2R1gCP-qyCCoUHE130_provenance.
- NP977861.RAr_EAnKL2rD0rZUsckO8yxDwVAvoq7__fTRcjl95vHgQ130_assertion description "[Prevalence of cagA and cagE genes in the patients with NUD, DU, GU and GC were 22 (64.7%), 28 (100%), 18 (90%), 10 (100%) and 25 (73.5%), 27 (96.4%), 19 (95%), 7 (70%), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977861.RAr_EAnKL2rD0rZUsckO8yxDwVAvoq7__fTRcjl95vHgQ130_provenance.
- NP723766.RAMeWFw6WHZ_nGpmolY76ofvenGqsuMJLVVU-1Ftdj-k0130_assertion description "[Prevalence of cagA and cagE genes in the patients with NUD, DU, GU and GC were 22 (64.7%), 28 (100%), 18 (90%), 10 (100%) and 25 (73.5%), 27 (96.4%), 19 (95%), 7 (70%), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP723766.RAMeWFw6WHZ_nGpmolY76ofvenGqsuMJLVVU-1Ftdj-k0130_provenance.
- NP977792.RA2NPu7kk6I-G9xWDH7xu7qj8lP0pA_esHxQoVBtiHHUw130_assertion description "[Prevalence of cagA and cagE genes in the patients with NUD, DU, GU and GC were 22 (64.7%), 28 (100%), 18 (90%), 10 (100%) and 25 (73.5%), 27 (96.4%), 19 (95%), 7 (70%), respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977792.RA2NPu7kk6I-G9xWDH7xu7qj8lP0pA_esHxQoVBtiHHUw130_provenance.